who is not a candidate for semaglutide Weight Loss: What to Know (2026 Guide) Semaglutide Eligibility Checklist in Canada:

3 Anecdotal reports of reduced drug craving in individuals using semaglutide, a new generation GLP-1RA, along with empirical studies showed its therapeutic benefits in alcohol and nicotine use disorders

Remarkably, one in three individuals achieved a 25% reduction in body weight, equating to a loss of 58 pounds Semaglutide (Wegovy): Wegovy users have experienced significant weight loss as well, with adults averaging a 15% reduction in body weight and a 16.1% decrease in BMI among children aged 12 and older Clinical trial comparisons: SURMOUNT-1 (Zepbound): Participants using the highest dose of Zepbound (15 mg) experienced an average weight loss of 21% after 72 weeks SURMOUNT-2 (Zepbound): In adults with type 2 diabetes, the same high dose led to a 12% weight loss after 72 weeks Wegovy trials: Comparable trials for Wegovy have shown an average weight loss of 15% from the starting weight in adults who are overweight or have obesity Cost considerations: The price of these medications is a factor to consider

300 mg of Wellbutrin is a commonly prescribed maintenance dosage

It can lead to abdominal pain, severe diarrhea, weight loss, and general fatigue

Here is the thing nobody in supplement marketing wants you to understand

Gynecomastia, or breast tissue growth in males, is yet another worry